Tempus AI

Latest news

• Recursion Pharmaceuticals (RXRX) Following Its Tempus AI Deal And The Valuation Debate (opens in a new tab)

  Simply Wall Street · Oct 2, 2026

• Tempus AI (NASDAQ:TEM) Shares Down 6.1% - Here's Why (opens in a new tab)

  MarketBeat · Oct 1, 2026

• Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026 (opens in a new tab)

  Business Wire · Oct 1, 2026

• What Does Today’s Signal Mean for Tempus AI (NASDAQ:TEM)? (opens in a new tab)

  Kalkine Media · Sep 30, 2026

• $Tempus AI (TEM.US)$ (opens in a new tab)

  Moomoo · Sep 30, 2026

• A trading plan governed the sale of 10,281 Tempus AI (TEM) shares by its diagnostics CEO at $85 each. (opens in a new tab)

  Stock Titan · Sep 29, 2026

• Tempus AI, Inc. Class A Bonds — Corporate Bond Rates (opens in a new tab)

  TradingView · Sep 29, 2026

• Why Tempus AI (TEM) Stock Is Down Today (opens in a new tab)

  Quiver Quantitative · Sep 29, 2026

• Current ratio of Tempus AI, Inc. Class A – HAN:F3M (opens in a new tab)

  TradingView · Sep 29, 2026

• FDA Clears Tempus AI Tool to Detect Mitral Regurgitation From ECGs (opens in a new tab)

  hlth.com · Sep 29, 2026

• Will FDA Clearance Change Tempus AI (TEM) Stock Narrative (opens in a new tab)

  Simply Wall Street · Sep 28, 2026

• Tempus AI receives FDA clearance for heart valve AI tool (opens in a new tab)

  Investing.com · Sep 28, 2026

• Tempus AI receives FDA clearance for heart valve AI tool By Investing.com (opens in a new tab)

  Investing.com Nigeria · Sep 28, 2026

• Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation (opens in a new tab)

  Business Wire · Sep 28, 2026

• Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike (ARKK:BATS) (opens in a new tab)

  Seeking Alpha · Sep 28, 2026

• Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike (opens in a new tab)

  TradingView · Sep 28, 2026

• Tempus AI CEO Lefkofsky sells $16.1m common stock (opens in a new tab)

  Investing.com · Sep 28, 2026

• Tempus AI CEO Ryan Fukushima sells $49,000 in stock (opens in a new tab)

  Investing.com · Sep 28, 2026

• Tempus AI CAO Ryan Bartolucci sells $529,650 in stock (opens in a new tab)

  Investing.com · Sep 28, 2026

• Tempus AI EVP Andrew Polovin sells 2,951 shares for $221,325 (opens in a new tab)

  Investing.com · Sep 28, 2026

• Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research (opens in a new tab)

  News-Medical · Sep 25, 2026

• #Day 10 - Looking to Take Profit on my tempus (opens in a new tab)

  Moomoo · Sep 25, 2026

• Tempus AI (TEM) Faces A Valuation Test As It Expands Into Whole Genome Sequencing (opens in a new tab)

  Simply Wall Street · Sep 25, 2026

• Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company Stock (opens in a new tab)

  MarketBeat · Sep 24, 2026

• Tempus AI(TEM.US) 10% Shareholder Sells US$19.37 Million in Common Stock (opens in a new tab)

  Moomoo · Sep 24, 2026

• Tempus AI CEO-linked entities sell 250,000 shares (opens in a new tab)

  Stock Titan · Sep 24, 2026

• Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know (opens in a new tab)

  TradingKey · Sep 24, 2026

• Tempus AI (NASDAQ:TEM) Trading 6.1% Higher - Time to Buy? (opens in a new tab)

  MarketBeat · Sep 24, 2026

• Tempus AI Chief Accounting Officer Sells $529,650 of Stock (opens in a new tab)

  fool.com · Sep 24, 2026

• RXRX Stock Rises As Tempus AI Deal Resets Growth Story (opens in a new tab)

  StocksToTrade · Sep 24, 2026